| 000 | 01300nam a2200301 a 4500 | ||
|---|---|---|---|
| 001 | 000527737 | ||
| 003 | AM-YeNLA | ||
| 005 | 20190426132057.0 | ||
| 008 | 070322s2006 sq |||||r|||||000|0|eng|d | ||
| 020 | _a92-832-1286-X | ||
| 041 | 0 | _aeng | |
| 245 | 0 | 0 |
_aCobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide : _b[IARC Working Group on the Evalution of Carcinogenic Risks to Humans, which met in Lyon, 7-14 October, 2003] / _cWorld Health Organization, International Agency for Research on Cancer. |
| 260 |
_aGeneva : _bWorld Health Organization, _c2006. |
||
| 300 |
_a335 p. ; _c20 cm. |
||
| 440 | 0 |
_aIARC Monographs on the Evaluation of Carcinogenic Risks to Humans _nvol. 86 _x1017-1606 |
|
| 504 | _aIncludes bibliographical refernces | ||
| 650 | 1 | 4 |
_aArsenic _vadverse effects |
| 650 | 1 | 4 | _aCarcinogens |
| 650 | 1 | 4 |
_aCobalt _vadverse effects |
| 650 | 1 | 4 |
_aGallium _vadverse effects |
| 650 | 1 | 4 |
_aIndium _vadverse effects |
| 650 | 1 | 4 | _aMetals |
| 650 | 1 | 4 |
_aVanadium compounds _vadverse effects |
| 650 | 1 | 4 |
_aTungsten _vadverse effects |
| 710 | 2 | _aWorld Health Organization | |
| 710 | 2 | _aInternational Agency for Research on Cancer | |
| 711 | 2 |
_aIARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Meeting _c(Lyon, France) |
|
| 999 |
_c457311 _d457311 |
||